Full-Time

Senior Director

Federal Government Affairs

Updated on 3/15/2025

Vertex Pharmaceuticals

Vertex Pharmaceuticals

1,001-5,000 employees

Develops medicines for serious diseases

Compensation Overview

$248.6k - $372.9k/yr

+ Bonus + Equity Awards

Senior, Expert

Company Does Not Provide H1B Sponsorship

Washington, DC, USA

Hybrid-Eligible: work remotely up to two days per week.

Category
Legal
Risk & Compliance
Legal & Compliance
Requirements
  • In depth understanding of how to influence policymakers, particularly Congress, to advance business interests with demonstrated record of success lobbying US federal government.
  • Experience anticipating policy trends and building lobbying strategies and supporting tactical plans to maximize opportunities to advance business interests.
  • Expert understanding of current political environment and policy-making processes at the federal level, particularly the legislative process and leveraging Congressional action to influence Regulatory processes.
  • Experience working across multiple functions within an organization to advance team and enterprise-level goals.
  • Ability to communicate effectively in both verbal and written formats, navigate complex organization, and drive enterprise-wide thinking.
  • Bachelor’s degree required
  • Typically requires 10 years of experience or the equivalent combination of education and experience.
Responsibilities
  • Assists the Vice President, Federal Government Affairs in successfully achieving primary functional area goals and serve as a key resource to Federal Government Affairs Directors.
  • Cultivate and maintains relationships with Members of Congress and their senior staff, the Administration, and White House officials important Vertex’s goals and objectives.
  • Lead proactive assessment of trends, policies and emerging issues and develop proposed strategies to effectively address issues that impact Vertex's business and patients.
  • Develop and manage legislative strategy to ensure Vertex’s interests are promoted and protected before Congress.
  • In partnership with Federal Government Affairs colleagues, develop and manage strategy to support Vertex's advocacy goals through political engagement of Congress and maximize impact of Vertex Political Action Committee.
  • Work closely with other relevant functional areas within the company, including corporate communications, investor relations, commercial, medical affairs, legal, regulatory and finance to provide political and strategic legislative expertise on activities critical to achieving corporate objectives.
Vertex Pharmaceuticals

Vertex Pharmaceuticals

View

Vertex Pharmaceuticals develops medicines for serious diseases, focusing on conditions like cystic fibrosis. The company conducts extensive research and development to create new drugs, often collaborating with other biotech firms to enhance its therapeutic offerings. One of its notable products is ivacaftor, which has shown effectiveness in treating cystic fibrosis. Vertex differentiates itself from competitors through its commitment to scientific innovation and strategic partnerships that expand its research capabilities. The goal of Vertex Pharmaceuticals is to improve the quality of life for patients with severe and life-threatening conditions by bringing effective treatments to market.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Boston, Massachusetts

Founded

1989

Simplify Jobs

Simplify's Take

What believers are saying

  • Vertex's partnership with Orna could lead to breakthroughs in gene therapy for SCD and TDT.
  • Recent investments indicate strong investor confidence in Vertex's growth potential.
  • Vertex's non-opioid pain therapy research shows commitment to innovative pain management solutions.

What critics are saying

  • Vertex is under investigation for potential securities law violations, posing legal risks.
  • Mixed Phase II data for suzetrigine may delay its development and affect investor confidence.
  • Heavy reliance on partnerships exposes Vertex to risks if collaborations fail.

What makes Vertex Pharmaceuticals unique

  • Vertex focuses on transformative medicines for serious diseases like cystic fibrosis.
  • The company invests heavily in R&D and strategic biotech partnerships.
  • Vertex's innovative gene and cell therapies set it apart in the biotech industry.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Company News

Stat News
Mar 18th, 2025
Genetics expert is first NIH director to leave under Trump

He will be replaced on an interim basis by Director Ian Smith, a former Vertex Pharmaceuticals executive.

GlobeNewswire
Mar 18th, 2025
Arbor Biotechnologies Announces $73.9 Million Series C Financing to Advance Novel Gene Editing Therapeutics

Series C led by ARCH Venture Partners and TCGX with significant participation from existing and new investors Financing extends Arbor’s cash runway into...

MarketBeat
Feb 14th, 2025
JSF Financial LLC Invests $751,000 in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

JSF Financial LLC invests $751,000 in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX).

MarketBeat
Jan 17th, 2025
Channel Wealth LLC Invests $716,000 in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Channel Wealth LLC invests $716,000 in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX).

Zenopa
Jan 8th, 2025
Vertex and Orna Partner for Innovative Gene Therapy Solutions

In a significant advancement for the biopharma industry, Vertex Pharmaceuticals has announced a partnership with Orna Therapeutics to develop cutting-edge in vivo gene editing therapies targeting sickle cell disease and beta thalassaemia.